Free fatty acids and insulin resistance

Chinese Pharmacological Bulletin

Volumn 21, Issue 2, 2005, Pages 145-149

  Liu, Chang Suo ^a   Shen, Zhu Fang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Free fatty acids; Insulin resistance; Signal transduction

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ANTIDIABETIC AGENT; ETOMOXIR; FATTY ACID; FIBRIC ACID DERIVATIVE; KBP 297; MURAGLITAZAR; NETOGLITAZONE; PIOGLITAZONE; RAGAGLITAZAR; ROSIGLITAZONE; SDZ FOX 988; TETRAHYDROLIPSTATIN; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; FATTY ACID METABOLISM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; SIGNAL TRANSDUCTION;

EID: 17144429634     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. McGarry JD. Banting Lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes[J]. Diabetes, 2002, 51 (1): 7-18.
2. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease[J]. Nature, 2000, 405(6785): 421-4.
3. Luiken JJ, Dyck DJ, Han XX et al. Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane[J]. Am J Physiol Endocrinol Metab, 2002, 282(2): 491-5.
4. Chao L, Marcus-Samuels B, Mason MM et al. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones[J] . J Clin Invest, 2000, 106(10): 1221-8.
5. Franckhauser S, Munoz S, Pujol A et al. Increased fatty acid reesterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance[J]. Diabetes, 2002, 51(3): 624-30.
6. Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity[J]. Nat Med, 2001, 7(8): 941-6.
7. Uysal KT, Wiesbrock SM, Marino MW et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function [J]. Nature, 1997, 389(6651): 610-4.
8. Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate[J]. J Biol Chem, 1999, 274(34): 24202-10.
9. Boden G, Cheung P, Stein TP et al. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis[J]. Am J Physiol Endocrinol Metab, 2002, 283(1): EI2-9.
10. Perseghin G, Scifo P, De Cobelli F et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: A 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents[J]. Diabetes, 1999, 48 (8): 1600-6.
11. Boden G, Lebed B, Schatz M et al. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects[J]. Diabetes, 2001, 50(7): 1612-7.
12. Pessin JE, Saltiel AR. Signaling pathways in insulin action: Molecular targets of insulin resistance[J]. J Clin Invest, 2000, 106 (2): 165-9.
13. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism[J]. Nature, 2001, 414(6865): 799-806.
14. Yu C, Chen Y, Cline GW et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle[J]. J Biol Chem, 2002, 277(52): 50230-6.
15. Olsen GS, Hansen BF. AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle[J]. Am J Physiol Endocrinol Metab, 2002, 283(5): 965-70.
16. Mayerson AB, Hundal RS, Dufour S et al. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes[J]. Diabetes, 2002, 51(3): 797-802.
17. Guerre-Millo M, Gervois P, Raspe E et al. Peroxisome proliferator- activated receptor alpha activators improve insulin sensitivity and reduce adiposity[J]. J Biol Chem, 2000, 275(22): 16638-42.
18. Ogilvie KM, Saladin R, Nagy TR et al. Activation of the retinoid X receptor suppresses appetite in the rat[J]. Endocrinology, 2004, 145(2): 565-73.
19. Kelley DE, Kuller LH, McKolanis TM et al. Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes[J]. Diabetes Care, 2004, 7(1): 33-40.